NIMC
PFE icon

NWQ Investment Management Company’s Pfizer PFE Stock Holding History

NWQ Investment Management Company’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-229,034
Closed -$6.83M – 161
2015
Q3 		$6.83M Buy
+229,034
New +$7.34M 0.11% 121
2015
Q2 		– Sell
-172,224
Closed -$5.68M – 156
2015
Q1 		$5.68M Buy
+172,224
New +$5.48M 0.07% 117

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

NWQ Investment Management Company's PFE Position: Q3 2018 in Review

NWQ Investment Management Company sold out of Pfizer (PFE) in Q3 2018, closing a stake of 715,809 shares — an estimated $24.6M sold.

NWQ Investment Management Company first reported a position in PFE in Q2 2013 and held it in 21 quarters. The position peaked at $357M in Q2 2013. 2,257 funds tracked by Wall St. Rank hold PFE as of Q3 2018.

  • NWQ Investment Management Company reported no remaining Pfizer position as of Q3 2018 after selling out during the quarter.
  • NWQ Investment Management Company sold 715,809 Pfizer shares in Q3 2018, an estimated $24.6M.
  • NWQ Investment Management Company first reported a position in Pfizer in Q2 2013 and held it in 21 quarters.
  • NWQ Investment Management Company's Pfizer position peaked at $357M in Q2 2013.
  • 2,257 funds tracked by Wall St. Rank held Pfizer as of Q3 2018.

Based on NWQ Investment Management Company's 13F filing for Q3 2018, filed 14 Nov 2018.